TLR4 and prostate carcinoma: Toll-like receptor 4 may also contribute to the development of other cancers besides prostate cancer, including, but not limited to, liver cancer, reproductive organ cancer, pancreatic cancer, intestinal cancer, and skin cancer (45, 70, 71).